H. pylori Testing in China: 13C Breath Test & Eradication Guide

Helicobacter pylori is the most widespread chronic bacterial infection in the world. The World Health Organization estimates it infects approximately half the global population — and the vast majority of those people have no idea they're carrying it. Most never develop significant symptoms. But for a meaningful minority, H. pylori is the direct cause of peptic ulcers, chronic gastritis, and — over years to decades — gastric cancer, the world's fifth most common cancer.

The remarkable thing is that H. pylori is detectable and, when found, curable with a short course of antibiotics. Yet in many Western countries, testing is only triggered by active symptoms, leaving a large population of asymptomatic carriers unaware of their infection and their elevated long-term risk.

This guide explains how H. pylori testing works — particularly the 13C urea breath test, the gold standard for detection — and how to access comprehensive GI screening including H. pylori testing through SinoCareLink's coordination in China.

What the Test Measures

H. pylori: A Brief Background

Helicobacter pylori is a spiral-shaped bacterium that colonizes the stomach lining. It's uniquely adapted to survive the acidic stomach environment by producing urease — an enzyme that breaks down urea into ammonia, locally neutralizing acid around the bacterium. This same urease activity is the basis for the breath test.

H. pylori infection typically begins in childhood through contaminated water, food, or close person-to-person contact. Prevalence is higher in populations with historical sanitation challenges and declines across birth cohorts as sanitation has improved — though even in high-income countries, H. pylori prevalence in adults over 50 can exceed 30–40%.

The 13C Urea Breath Test

The 13C urea breath test (13C-UBT) is considered the most accurate, non-invasive test for detecting active H. pylori infection. Here's how it works:

1. You fast for at least 4–6 hours before the test (some protocols specify 4 hours minimum, others overnight fast — your coordinator will specify the requirement).
2. You drink a small amount of a solution containing 13C-labeled urea — urea in which the carbon atoms are the stable isotope carbon-13 (non-radioactive, safe, and naturally occurring in small amounts in all food).
3. If H. pylori is present in your stomach, the bacteria's urease enzyme rapidly breaks down the labeled urea, releasing 13CO₂ (carbon dioxide with the 13C isotope).
4. This labeled CO₂ is absorbed into the bloodstream and exhaled through the lungs.
5. You breathe into a collection bag approximately 20–30 minutes after drinking the solution. The ratio of 13CO₂ to 12CO₂ in your exhaled breath is measured by mass spectrometry.

A positive result (elevated 13CO₂ ratio) confirms active H. pylori infection. A negative result effectively rules out active infection, with high sensitivity and specificity (both generally above 90–95%).

The 13C-UBT is preferred over serology (blood antibody test) for most purposes because:
- Serology detects past exposure, not active infection — antibodies remain positive for months to years after successful eradication, making serology useless for confirming cure.
- The breath test detects active bacterial presence — making it the test of choice both for initial diagnosis and for confirming successful eradication after treatment.

Other H. pylori Tests

Stool antigen test (SAT): Also detects active infection with reasonable accuracy. Less preferred than 13C-UBT for confirmatory testing post-treatment due to slightly lower performance characteristics in some studies.

Rapid urease test (RUT) / biopsy-based tests: During gastroscopy, a biopsy from the stomach lining can be tested for urease activity or examined histologically. Highly accurate but requires endoscopy. In the context of the bundled GI package, if gastroscopy is already being performed, rapid urease testing or biopsies can be included.

Serology (IgG antibodies): Useful for initial prevalence surveys but not for confirming active infection or eradication due to persistent antibody positivity after cure.

Who Should Get Tested for H. pylori

Testing is appropriate for:

• Anyone with active peptic ulcer disease or a history of peptic ulcers — H. pylori is the cause in approximately 90% of duodenal ulcers and 70–80% of gastric ulcers. Eradication is standard care.
• Uninvestigated dyspepsia (persistent upper abdominal discomfort, early satiety, bloating, belching) in adults — the "test and treat" strategy is recommended by most guidelines (including ACG and British Society of Gastroenterology) for dyspeptic patients under 60 without alarm features.
• Family history of gastric cancer — first-degree relatives of gastric cancer patients have elevated H. pylori prevalence and elevated cancer risk; eradication may reduce risk.
• Individuals from high-prevalence regions — including East Asia, Eastern Europe, and Latin America — who have not been previously tested.
• Gastric MALT lymphoma — a rare gastric lymphoma often directly caused by H. pylori; eradication alone can achieve remission in early-stage disease.
• Anyone undergoing gastroscopy for any reason — adding H. pylori testing to an existing endoscopy is straightforward.
• Asymptomatic individuals who want a complete GI risk assessment — in the context of a deep GI screening package, including H. pylori testing adds meaningful information at negligible incremental cost.
• People on long-term NSAIDs or aspirin — H. pylori and NSAID use act synergistically to increase peptic ulcer risk; testing and treating H. pylori before or during long-term NSAID use is recommended by major guidelines.
• After prior H. pylori treatment — to confirm successful eradication (test at least 4 weeks after completing antibiotics and 2 weeks after stopping proton pump inhibitors).

Why Test (and Treat) in China

Context: China has very high H. pylori prevalence

China has one of the highest H. pylori prevalence rates in the world — historically estimated at 50–60% of the population, though rates are declining in younger birth cohorts. Gastric cancer incidence in China is among the highest globally. As a result, Chinese gastroenterologists have exceptional clinical experience with H. pylori management, and testing infrastructure is well-developed.

The 13C breath test is bundled in the GI package

The GI & Digestive Health Screening package at $799 includes the 13C urea breath test as a standard component alongside sedated gastroscopy, abdominal MRI, tumor markers, and liver assessment. If H. pylori is confirmed on breath test, the contemporaneous gastroscopy findings (gastritis pattern, any ulcers, mucosal abnormalities) provide immediate clinical context.

Cost

In the US, a standalone 13C breath test can cost $100–$300 depending on setting. The real access challenge is that many general practitioners don't routinely offer it — it's often only available through specialist gastroenterology practices. In China, it's a standard, widely available outpatient test included as a bundle component.

One visit, complete picture

A key advantage of the bundled approach: if H. pylori is positive on breath test AND gastroscopy shows associated gastritis or early mucosal changes, the full picture is established in one visit. This compresses what might take months of referral management in Western systems into a single coordinated day.

H. pylori Eradication: What Treatment Looks Like

If H. pylori is detected, treatment is a short course of antibiotics combined with acid suppressors. The standard first-line regimens include:

Triple therapy (traditional): A proton pump inhibitor (PPI) + two antibiotics (typically clarithromycin + amoxicillin, or metronidazole as an alternative) for 10–14 days.

Bismuth quadruple therapy: PPI + bismuth + tetracycline + metronidazole for 10–14 days. Often used in areas with higher clarithromycin resistance, or as second-line after triple therapy failure.

Concomitant and sequential therapies: Increasingly preferred in regions with higher antibiotic resistance.

Antibiotic resistance is a significant issue with H. pylori eradication. Clarithromycin resistance has risen in many countries and is a reason first-line triple therapy fails in a meaningful proportion of cases. In China, empirical bismuth quadruple therapy is often first-line due to local resistance patterns — Chinese gastroenterologists are well-positioned to select the right regimen based on local epidemiology.

After completing treatment: Confirmation of successful eradication with a 13C breath test is strongly recommended — at least 4 weeks after completing antibiotics and at least 2 weeks after stopping PPIs. This is critical because not all treatment courses succeed on the first attempt.

SinoCareLink can coordinate eradication treatment prescription during or following your visit, and can arrange a follow-up confirmatory breath test on a subsequent trip or assist with arranging this through your home physician.

How the Process Works with SinoCareLink

SinoCareLink is a coordination service for English-speaking patients accessing Chinese healthcare. We coordinate scheduling, translation, and on-site companionship — we are not a medical provider.

1. Free consultation — Contact us via /pages/contact. Tell us whether you're testing for the first time, confirming eradication after treatment, or including it as part of a broader GI screening visit.
2. Preparation instructions — The 13C breath test requires a specific fast. If you're combining it with gastroscopy (as part of the full GI package), you'll fast overnight for the endoscopy, which covers the breath test requirement too. If you've had recent antibiotics or PPIs, we'll clarify the required washout period.
3. On-site support — A bilingual coordinator accompanies you. The breath test is simple — drink a solution, wait 20–30 minutes, breathe into a bag. Our coordinator explains each step.
4. Results — The 13C breath test result is typically available within a few hours to the same day. If positive, the gastroenterologist can discuss eradication treatment options during the same visit.
5. Follow-up — If eradication treatment is prescribed, we provide the English prescription information and can help arrange a follow-up confirmatory breath test.

Frequently Asked Questions

How accurate is the 13C urea breath test?
The 13C-UBT has sensitivity and specificity both generally above 90–95% for detecting active H. pylori infection. It is widely considered the most accurate non-invasive test for this purpose and is endorsed by major gastroenterology guidelines (ACG, European Helicobacter Study Group) as the preferred method for both initial diagnosis and confirmation of eradication.

What should I avoid before the test?
You must fast for at least 4–6 hours before the test. Additionally, for accurate results:
- Stop proton pump inhibitors (PPIs) (omeprazole, lansoprazole, pantoprazole, etc.) at least 2 weeks before the test — PPIs can suppress H. pylori activity enough to cause a false-negative.
- Stop antibiotics at least 4 weeks before the test.
- Stop bismuth-containing products (Pepto-Bismol, etc.) at least 2 weeks before the test.
Failure to observe these washout periods is the most common cause of false-negative breath test results.

Can I have the test if I'm pregnant?
The 13C-UBT uses a stable (non-radioactive) isotope and is generally considered safe. However, most guidelines recommend deferring elective testing in pregnancy and managing symptomatic cases clinically, then testing post-partum. Discuss with your physician.

My previous treatment failed — what are my options?
H. pylori eradication failure is common with first-line therapy, especially in regions with high clarithromycin resistance. Second-line options typically include bismuth quadruple therapy (if not used first) or levofloxacin-based regimens. In China, antibiotic susceptibility testing (via culture from gastric biopsy) can guide tailored therapy — this is an option worth considering for recurrent treatment failures.

Does testing H. pylori status matter if I have no symptoms?
Yes, for several reasons. H. pylori-associated gastric cancer develops over decades, long before symptoms appear. Eradication of H. pylori substantially reduces gastric cancer risk, particularly when done before preneoplastic changes develop. Asymptomatic carriers with risk factors (family history of gastric cancer, atrophic gastritis on prior endoscopy) particularly benefit from the "test and treat" approach.

What happens if H. pylori is found during my gastroscopy biopsy but the breath test was negative?
This can occur if the breath test had a false-negative (due to PPI use, small bacterial load, or technical factors) or if H. pylori distribution is patchy. A positive gastric biopsy urease test or histology is also a valid basis for diagnosing active infection and proceeding with eradication. The combination of breath test and endoscopy in the bundled package provides complementary detection layers.

Is H. pylori the same as a stomach ulcer?
No — H. pylori is a bacterial infection that is the most common cause of peptic (stomach and duodenal) ulcers, but not all H. pylori infections cause ulcers, and not all ulcers are caused by H. pylori. NSAIDs are the other major cause. H. pylori infection without ulcers is the more common presentation.